Fig. 3From: Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patientsClinical outcomes of Luminal-like patients according to RS, TILs, and PD-L1 level. BCFI and BCSS were compared by RS and TIME markers using Kaplan–Meier curves. BCFI breast cancer-free interval, RS recurrence score, BCSS breast cancer-specific survival, TIL tumor infiltrating lymphocyte, PD-L1 programmed cell death-ligand 1Back to article page